206 related articles for article (PubMed ID: 8611047)
1. [Novel targets for cancer chemotherapy].
Inoue S
Gan To Kagaku Ryoho; 1996 Jan; 23(2):191-201. PubMed ID: 8611047
[TBL] [Abstract][Full Text] [Related]
2. New targets for cancer chemotherapy.
Murgo AJ; Dancey J; Eckhardt SG; Hidalgo M; Arbuck SG; Zerivitz K; Blaylock BA
Cancer Chemother Biol Response Modif; 2002; 20():239-72. PubMed ID: 12703208
[No Abstract] [Full Text] [Related]
3. Preclinical and clinical development of novel agents that target the protein kinase C family.
Serova M; Ghoul A; Benhadji KA; Cvitkovic E; Faivre S; Calvo F; Lokiec F; Raymond E
Semin Oncol; 2006 Aug; 33(4):466-78. PubMed ID: 16890801
[TBL] [Abstract][Full Text] [Related]
4. Intracellular signal transduction pathway proteins as targets for cancer therapy.
Adjei AA; Hidalgo M
J Clin Oncol; 2005 Aug; 23(23):5386-403. PubMed ID: 15983388
[TBL] [Abstract][Full Text] [Related]
5. Novel targets for therapy in paediatric oncology.
Estlin EJ
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):141-50. PubMed ID: 12476788
[TBL] [Abstract][Full Text] [Related]
6. Modulation of apoptosis signaling for cancer therapy.
Fulda S; Debatin KM
Arch Immunol Ther Exp (Warsz); 2006; 54(3):173-5. PubMed ID: 16652217
[TBL] [Abstract][Full Text] [Related]
7. Bypassing cancer drug resistance by activating multiple death pathways--a proposal from the study of circumventing cancer drug resistance by induction of necroptosis.
Hu X; Xuan Y
Cancer Lett; 2008 Feb; 259(2):127-37. PubMed ID: 18082322
[TBL] [Abstract][Full Text] [Related]
8. Integrins and extracellular matrix: a novel mechanism of multidrug resistance.
Elliott T; Sethi T
Expert Rev Anticancer Ther; 2002 Aug; 2(4):449-59. PubMed ID: 12647988
[TBL] [Abstract][Full Text] [Related]
9. Multitargeted therapy: can promiscuity be praised in an era of political correctness?
Jimeno A; Hidalgo M
Crit Rev Oncol Hematol; 2006 Aug; 59(2):150-8. PubMed ID: 16843676
[TBL] [Abstract][Full Text] [Related]
10. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.
Moretti L; Yang ES; Kim KW; Lu B
Drug Resist Updat; 2007; 10(4-5):135-43. PubMed ID: 17627865
[TBL] [Abstract][Full Text] [Related]
11. Anti-apoptotic proteins-targets for chemosensitization of tumor cells and cancer treatment.
Kostanová-Poliaková D; Sabová L
Neoplasma; 2005; 52(6):441-9. PubMed ID: 16284687
[TBL] [Abstract][Full Text] [Related]
12. Key cancer cell signal transduction pathways as therapeutic targets.
Bianco R; Melisi D; Ciardiello F; Tortora G
Eur J Cancer; 2006 Feb; 42(3):290-4. PubMed ID: 16376541
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in understanding the cell death pathways activated by anticancer therapy.
Kim R
Cancer; 2005 Apr; 103(8):1551-60. PubMed ID: 15742333
[TBL] [Abstract][Full Text] [Related]
14. [Cancer chemotherapy and apoptosis].
Mashima T; Naito M; Kataoka S; Tsuruo T
Nihon Rinsho; 1996 Jul; 54(7):1935-42. PubMed ID: 8741691
[TBL] [Abstract][Full Text] [Related]
15. Redox-sensitive signaling factors as a novel molecular targets for cancer therapy.
Pennington JD; Wang TJ; Nguyen P; Sun L; Bisht K; Smart D; Gius D
Drug Resist Updat; 2005 Oct; 8(5):322-30. PubMed ID: 16230045
[TBL] [Abstract][Full Text] [Related]
16. Ceramide synthesis and metabolism as a target for cancer therapy.
Reynolds CP; Maurer BJ; Kolesnick RN
Cancer Lett; 2004 Apr; 206(2):169-80. PubMed ID: 15013522
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of drug resistance.
Longley DB; Johnston PG
J Pathol; 2005 Jan; 205(2):275-92. PubMed ID: 15641020
[TBL] [Abstract][Full Text] [Related]
18. Overcoming drug resistance in multiple myeloma: the emergence of therapeutic approaches to induce apoptosis.
Yang HH; Ma MH; Vescio RA; Berenson JR
J Clin Oncol; 2003 Nov; 21(22):4239-47. PubMed ID: 14615454
[TBL] [Abstract][Full Text] [Related]
19. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists.
Ashkenazi A
Nat Rev Drug Discov; 2008 Dec; 7(12):1001-12. PubMed ID: 18989337
[TBL] [Abstract][Full Text] [Related]
20. [Antimitochondrial agents: a new class of anticancer agents].
André N; Rome A; Carré M;
Arch Pediatr; 2006 Jan; 13(1):69-75. PubMed ID: 16298120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
